undefined undefined
NaN.000
NaN.00%
AbCellera (NASDAQ:ABCL) has inked an agreement with Viking Global Investors and ArrowMark Partners to develop new antibody drug programs, with an initial focus on immunology. The partnership also sees...
05-01 23:44
蓝鲸财经 何天骄 大健康产业是当前最具活力和潜力的产业之一,也是全球未来产业竞争的热点领域,正在成为推动新质生产力的核心力量。 4月30日,“新智人才,新质未来...
04-30 20:57
In the preceding three months, 27 analysts have released ratings for Biogen (NA...
04-30 01:01
In a report released yesterday, Brian Skorney from Robert W. Baird maintained a...
04-26 13:58
巴克莱:维持Biogen(BIIB.US)评级,由持股观望调整至持股观望评级, 目标价由215.00美元调整至200.00美元。
04-26 02:11
Biogen Inc (NASDAQ:BIIB) reported better-than-expected earnings for its first q...
04-25 20:53
三大期指盘前跌势扩大,Meta绩后暴跌14%“吓崩”科技股情绪!高盛悲观上调今年美国通胀预期;背靠微软的云数据安全商“Rubrik”今晚在纽交所上市>>
04-25 20:36
加拿大投行Canaccord Genuity将渤健公司目标价从305美元上调至308美元。
04-25 14:20
美國藥廠渤健(Biogen)(BIIB.US)公布首季業績。季度純利按年升1%至3.93億美元,每股季度攤薄純利2.7美元,經調整後為3.67美元,較市場預期多...
04-25 08:56